LNTH:NASDAQ
Lantheus Holdings Inc
$100.25
arrow_downward
-0.14%(-0.14) 1D
$100.25
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 11, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LNTH...
Open
$100.51
High
$100.51
Low
$100.18
Mkt. cap
6.55B
Avg. vol.
1.76M
Volume
1.21M
P/E ratio
24.25
52-wk high
$111.86
52-wk low
$49.67
EPS
$4.13
Beta
-0.03
Shares outstanding
65.30M
No. of employees
1K
Open
$100.51
High
$100.51
Low
$100.18
Mkt. cap
6.55B
Avg. vol.
1.76M
Volume
1.21M
P/E ratio
24.25
52-wk high
$111.86
52-wk low
$49.67
EPS
$4.13
Beta
-0.03
Shares outstanding
65.30M
No. of employees
1K
News stories
From web sources and news partners
Stock Traders Daily
·
9 hours ago
(LNTH) Risk Channels and Responsive Allocation
STL.News
·
17 hours ago
LNTH, ITGR and CZR Deals Face Investor Scrutiny
PR Newswire
·
18 hours ago
Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders?
Profile
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.
Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.
Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade. Wikipedia
About Lantheus Holdings Inc
CEO-
Employees1.19K
Founded1956
HeadquartersNorth Billerica, Massachusetts, United States
SectorMedical device
Websitelantheus.com